临床 试验
- Study of Zanubrutinib (BGB-3111) in Patients With Marginal Zone Lymphoma条件:淋巴瘤分子:Zanubrutinib
- Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma条件:胃癌, 食道癌分子:Tislelizumab
- The Study of Lifirafenib in Chinese Subjects With Local Advanced or Metastatic Malignant Solid Tumors条件:晚期实体肿瘤分子:Lifirafenib
- A Study of Zanubrutinib Versus Ibrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia条件:白血病, 淋巴瘤分子:Zanubrutinib
- A Phase 1b Study to Assess Sitravatinib in Combination With Tislelizumab in Patients With Advanced Solid Tumors条件:晚期实体肿瘤分子:Tislelizumab
- Study of BGB-A425 in Combination With Tislelizumab in Advanced Solid Tumors条件:晚期实体肿瘤分子:Tislelizumab
- Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination Deficiency条件:分子:Pamiparib
- A Study Evaluating the Efficacy and Safety of Tislelizumab Versus Chemotherapy in Advanced Non-Squamous NSCLC条件:肺癌分子:Tislelizumab
- A Study of Tislelizumab in Combination With Chemotherapy Versus Chemotherapy in Advanced Lung Cancer条件:肺癌分子:Tislelizumab
- A Study of Tislelizumab Versus Chemotherapy as First Line Treatment in Patients With Advanced Esophageal Squamous Cell Carcinoma (ESCC)条件:食道癌分子:Tislelizumab